Back to Directory
Nascent Therapeutics
East of England
Founded 2025
Small molecule regulators of mitochondrial transfer for age related disease
Nascent Therapeutics is a biotechnology company developing small molecule therapies that regulate mitochondrial transfer between cells.
The company's discovery platform identifies compounds that promote the uptake of healthy mitochondria into damaged cells, or block cancer cells from taking mitochondria from surrounding tissue.
Nascent is initially targeting Parkinson's disease and oncology, aiming to deliver disease modifying treatments rather than purely symptomatic management, with a longer term ambition spanning neurodegeneration and healthy ageing.